In the past week, AGEN stock has gone down by -30.18%, with a monthly decline of -45.81% and a quarterly plunge of -49.22%. The volatility ratio for the week is 19.17%, and the volatility levels for the last 30 days are 11.83% for Agenus Inc The simple moving average for the past 20 days is -37.59% for AGEN’s stock, with a -66.11% simple moving average for the past 200 days.
Is It Worth Investing in Agenus Inc (NASDAQ: AGEN) Right Now?
The stock has a 36-month beta value of 1.33. Opinions on the stock are mixed, with 1 analysts rating it as a “buy,” 2 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for AGEN is 19.91M, and at present, short sellers hold a 0.60% of that float. On April 16, 2024, the average trading volume of AGEN was 553.66K shares.
AGEN) stock’s latest price update
The stock price of Agenus Inc (NASDAQ: AGEN) has dropped by -20.25 compared to previous close of 8.15. Despite this, the company has seen a fall of -30.18% in its stock price over the last five trading days. The Motley Fool reported 2024-04-08 that Shares of Agenus are way down this year, but the cancer drug developer still has some interesting assets. An experimental cancer therapy that just started phase 2 trials could generate more than $1 billion in milestone payments from Bristol Myers Squibb.
Analysts’ Opinion of AGEN
Many brokerage firms have already submitted their reports for AGEN stocks, with Robert W. Baird repeating the rating for AGEN by listing it as a “Outperform.” The predicted price for AGEN in the upcoming period, according to Robert W. Baird is $8 based on the research report published on June 06, 2023 of the previous year 2023.
Robert W. Baird, on the other hand, stated in their research note that they expect to see AGEN reach a price target of $80, previously predicting the price at $60. The rating they have provided for AGEN stocks is “Outperform” according to the report published on June 06th, 2023.
H.C. Wainwright gave a rating of “Buy” to AGEN, setting the target price at $8 in the report published on February 28th of the previous year.
AGEN Trading at -48.00% from the 50-Day Moving Average
After a stumble in the market that brought AGEN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -84.74% of loss for the given period.
Volatility was left at 11.83%, however, over the last 30 days, the volatility rate increased by 19.17%, as shares sank -39.81% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -48.84% lower at present.
During the last 5 trading sessions, AGEN fell by -30.18%, which changed the moving average for the period of 200-days by -80.99% in comparison to the 20-day moving average, which settled at $10.20. In addition, Agenus Inc saw -60.74% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at AGEN starting from ARMEN GARO H, who purchase 500,000 shares at the price of $0.65 back on Feb 15 ’24. After this action, ARMEN GARO H now owns 625,969 shares of Agenus Inc, valued at $324,050 using the latest closing price.
WIINBERG ULF, the Director of Agenus Inc, purchase 25,000 shares at $0.76 during a trade that took place back on Nov 15 ’23, which means that WIINBERG ULF is holding 124,063 shares at $19,000 based on the most recent closing price.
Stock Fundamentals for AGEN
Current profitability levels for the company are sitting at:
- -1.02 for the present operating margin
- -0.13 for the gross margin
The net margin for Agenus Inc stands at -1.6. The total capital return value is set at -2.75.
Based on Agenus Inc (AGEN), the company’s capital structure generated 2.31 points at debt to capital in total, while cash flow to debt ratio is standing at -0.74. The debt to equity ratio resting at -1.77. The interest coverage ratio of the stock is -1.61.
Currently, EBITDA for the company is -146.52 million with net debt to EBITDA at -1.89. When we switch over and look at the enterprise to sales, we see a ratio of 2.62. The receivables turnover for the company is 6.05for trailing twelve months and the total asset turnover is 0.5. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.44.
Conclusion
To sum up, Agenus Inc (AGEN) has seen a bad performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
